Generic drug company Alphapharm has lost a bid for documents it claimed would show Sanofi-Aventis suspected as early as 2015 that patents for one of its injector pens may be invalid.
Hytera Communications has until Thursday to reveal what evidence has been or will be withheld from Motorola in their intellectually property battle in compliance with strict Chinese state security and cybersecurity laws.
Generic drug maker Dr Reddy’s Laboratories has reached a settlement with US-based Millennium Pharmaceuticals, agreeing to be restrained from selling a cheap version of cancer drug Velcade in Australia.
Facing a trade mark infringement lawsuit for selling products under the name Scotch Whisky, Australian liquor retailer D’Aquino Bros has filed a claim of its own, arguing the words are a generic description used in Australia to mean any whisky from Scotland.
On the eve of a hearing into damages, rival pavement engineering companies have resolved a copyright dispute that continued important law on what constitutes infringement of computer software source code.
A gamer has admitted he violated the copyright forĀ Take-Two Interactive’s popularĀ Grand Theft Auto video game by making unauthorised changes to the game that allowed him to manipulate the actions of other online players without their consent.
A Federal Court judge has put an appeal by Aristocrat of an IP Australia ruling that revoked four of its gaming patents on hold pending the outcomes of two highly anticipated cases over the patentability of computer software.
Confectionery giant Mars has successfully opposed an application by Kraft Foods for an Australian patent for chocolate that doesn’t melt in the summer months.
Bodum, maker of the popular glass French press coffee maker, has sued an Australian company for allegedly copying the design and getup of its iconic device, on the heels of winning a $4 million judgment in the US over a copycat device.Ā
Animal drug giant Merial is pushing on with its opposition to rival Intervet’s bid to a patent a non-drug resistant injectable formula for treating animal parasites, filing an appeal in the Federal Court after it came up short in its challenge before IP Australia.